Research Hub

Protocol Reference, Planner & Assistant

Three research tools in one place: what the published literature reports with citations attached, a multi-draw schedule planner that does arithmetic on your own numbers, and the personal research agent that comes with every purchase.

Literature Protocol Reference

Quantities reported in published studies, with the research model and citation attached. These are records of what the literature reports — not recommendations, not human doses, and not advice.

Retatrutide

Triple GLP-1 / GIP / glucagon receptor agonist studied in metabolic and energy-expenditure research models.

Phase 2 clinical trial (published, adults with obesity)

1 mg to 12 mg per administration

Frequency reported
Once weekly
Study duration
48 weeks
Jastreboff et al., NEJM 2023Triple–Hormone-Receptor Agonist Retatrutide for Obesity — a Phase 2 Trial. N Engl J Med 389:514–526.

Phase 2 clinical trial (published, type 2 diabetes)

0.5 mg to 12 mg per administration

Frequency reported
Once weekly
Study duration
36 weeks
Rosenstock et al., The Lancet 2023Retatrutide in people with type 2 diabetes: a randomised, double-blind, placebo- and active-controlled, parallel-group, phase 2 trial. Lancet 402:529–544.

Escalation schedule as described in the published protocol

  1. Weeks 1–4Lowest study arm quantityPublished trials began at the low end of the range and held it for four weeks before any escalation.
  2. Weeks 5–8First escalation incrementEscalation in the published protocol occurred at four-week intervals, not weekly.
  3. Weeks 9+Held or escalated to target armTrial arms were fixed targets; escalation stopped once the assigned arm quantity was reached.

Stability as reported

Lyophilised: stable at -20°C for the labelled shelf life; short excursions to 2–8°C are tolerated. Reconstituted: 2–8°C, commonly reported as usable for up to 28–30 days in bacteriostatic water.

Handling

Reconstitute down the vial wall, swirl rather than shake, and protect from light. Avoid repeated freeze–thaw of the reconstituted solution.

These figures describe what researchers used in the cited studies, in the model organism or trial population stated. Novexa Labs compounds are supplied for laboratory research use only and are not for human or animal consumption. Nothing on this page is medical advice or a personalised protocol.

Reconstitution & Multi-Draw Schedule Planner

Plans a study period from numbers you choose: how many draws a vial yields, how long the reconstituted vial lasts against the reported cold-storage window, and how much material remains unused. It performs arithmetic on your inputs — it does not select them for you.

Draw frequency

Draws per vial

40

40.00 theoretical

Units per draw

5.0

0.050 mL

Vial lifespan at this frequency

40 days

Reported cold-storage window: ~30 days at 2–8°C

Full study period

40 days

40 draws across 1 vial

Unused material

Approximately 2,500 mcg per vial (25.0%) is not drawn — either a part-draw remainder or material left after the reported cold-storage window closes. Adjusting the water volume or the draw size changes this.

At this frequency the vial would take 40 days to finish, which is longer than the ~30-day window commonly reported for reconstituted peptides held at 2–8°C. Only about 30 draws fall inside that window. Researchers commonly reconstitute a smaller volume, aliquot and freeze at -20°C, or use a smaller vial.

Every figure here is arithmetic on the values you entered, or a description of a published study's structure. This planner does not select a quantity, a frequency or a schedule for any person, and it is not medical advice.

Your Personal Research Companion

Included with every purchase

Buy anything from Novexa Labs and you get a research companion that already knows what is in your order. This is the page it lives on:

The My Companion page: a research profile and purchased vials on the left, a conversation with your companion on the right.
The My Companion page, signed in — example account
1

Your details, entered once

Weight, age, goal and experience are optional. Fill them in and your companion carries them into every conversation from then on — no repeating yourself.

2

Your purchases appear automatically

Everything you have ordered is listed with its vial size and storage guidance. Your companion works from the same list, so it always knows which material you actually hold.

3

The limits are stated up front

Individualised dosing, symptom questions and blood-work interpretation are refused every time — enforced outside the model, not left to its judgement.

4

Answers use your vial and your numbers

Ask about reconstitution and it works from the strength you own — concentration, draw volume, syringe units and doses per vial — grounded in Novexa's own research library.

Reconstitution Basics

Add water slowly

Run bacteriostatic water down the inside wall of the vial. Never inject the stream directly onto the lyophilised powder.

Swirl, don't shake

Rotate the vial gently until fully dissolved. Agitation can denature the peptide chain.

Store cold

Reconstituted vials belong at 2–8°C and are typically stable for up to 30 days. Unopened lyophilised vials store best frozen.

More water, easier measuring

Adding 2 mL instead of 1 mL doubles the draw volume, which makes small measurements far more accurate.

These tools are laboratory reference aids only. They report what published studies describe and perform arithmetic on values you enter. Novexa Labs products are supplied strictly for research purposes and are not intended for human or animal consumption, and nothing here is medical advice.